Sign Up Today and Learn More About NewLeaf Symbiotics Stock
Invest in or calculate the value of your shares in NewLeaf Symbiotics or other pre-IPO companies through EquityZen's platform.
NewLeaf Symbiotics Stock (NESM)
NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.
About NewLeaf Symbiotics Stock
Founded
1999
Headquarters
St Louis, MO, US
Industries
Software, Artificial Intelligence, Data and Analytics
NewLeaf Symbiotics Press Mentions
Stay in the know about the latest news on NewLeaf Symbiotics
Agricultural Biotechnology Market Trends, Analysis, and Forecast 2025-2034 | CRISPR and RNAi Drive Innovations, Bioengineered Microbes Enhance Soil Health and Reduce Chemical Inputs
globenewswire • Jun 30, 2025
Methylobacterium treated plants, plant parts, and seeds
patents • Apr 02, 2025
Methylobacterium compositions and plants, plant parts and seeds coated …
patents • Apr 02, 2025
Methods for improving plant response to pests and pathogens
patents • Apr 02, 2025
Microbial fermentation methods and compositions
patents • Feb 08, 2025
NewLeaf Symbiotics Management
Leadership team at NewLeaf Symbiotics
Co-Founder
Thomas Laurita
Board of Directors
Kevin Kopczynski
Join now and verify your accreditation status to gain access to:
- NewLeaf Symbiotics Current Valuation
- NewLeaf Symbiotics Stock Price
- NewLeaf Symbiotics Management
- Available deals in NewLeaf Symbiotics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- NewLeaf Symbiotics Cap Table and Funding History by Share Class and Liquidity Preferences
- NewLeaf Symbiotics Revenue and Financials
- NewLeaf Symbiotics Highlights
- NewLeaf Symbiotics Business Model
- NewLeaf Symbiotics Risk Factors
- NewLeaf Symbiotics Research Report from SACRA Research
Trading NewLeaf Symbiotics Stock
How to invest in NewLeaf Symbiotics stock?
Accredited investors can buy pre-IPO stock in companies like NewLeaf Symbiotics through EquityZen funds. These investments are made available by existing NewLeaf Symbiotics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell NewLeaf Symbiotics stock?
Shareholders can sell their NewLeaf Symbiotics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
